Author

Mark Dawkins

Institutions: University of Oxford, Oxford University Hospitals NHS Trust

Observed institutions: St Bartholomew's Hospital, University of Dundee, Barts Health NHS Trust, University of Oxford, Whipps Cross University Hospital, Oxford University Hospitals NHS Trust, Medical Research Council

OpenAlex ID: A5031576826

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 493

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 369

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 324

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 290

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 129

Utility of Troponin I and Cardiac Magnetic Resonance in the Assessment of Cardiac Involvement in Idiopathyc Inflammatory Myositis

2020 · Georgiana Luisa Baca, Mark Dawkins, et al. · Journal of the American College of Cardiology

Works count: 6

Citation count: 1,604

H-index: 5

I10-index: 5